Greg Guzauskas

Greg Guzauskas is a Senior Research Scientist at the University of Washington School of Pharmacy, Department of Pharmacy, affiliated with the CHOICE Institute (Comparative Health Outcomes, Policy, and Economics). His research focuses on health economics, outcomes research, and pharmacoeconomics, with particular expertise in cost-effectiveness analysis of medical interventions.

Dr. Guzauskas' research interests span Health Economics, Outcomes Research, Pharmacoeconomics, and Decision Modeling. His work primarily examines the economic value of medical interventions across various disease areas including genomics, HIV treatment, Huntington's disease, and cancer therapies. He employs sophisticated modeling techniques to evaluate long-term health outcomes and resource utilization.

His recent publications demonstrate a strong trend toward genomic medicine economics and chronic disease management. Guzauskas has contributed significantly to understanding the cost-effectiveness of population genomic screening programs for hereditary conditions, HIV cure strategies, and treatments for rare neurological disorders. His work often bridges clinical medicine with health policy decision-making.

His scientific contributions include numerous peer-reviewed publications in high-impact journals such as Annals of Internal Medicine, Journal of the International AIDS Society, and Genetics in Medicine. His research has informed healthcare policy discussions regarding resource allocation and value-based medicine.

As a researcher at the CHOICE Institute, Guzauskas collaborates with interdisciplinary teams to evaluate healthcare interventions through economic modeling and outcomes research. His work supports evidence-based decision making in healthcare policy and practice.